Skip to content
drillr.ai

BEAT

HeartBeam, Inc.

NASDAQ · USHealthcareMedical - Healthcare Information Services
$0.57+1.68%

Price as of Jul 20, 2026

BEAT news

HeartBeam, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

    HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition * Company will license its 3D ECG signal technology to established partners, moving beyond direct medical device sales * Advancing toward heart attack detection as a key expansion of the platform * Tailoring its technology to fit each market, while operating with a leaner, more focused structure * Company to provide more details on strategy as part of Second

    Business Wire ·

  2. HeartBeam Reports First Quarter 2026 Results

    HeartBeam Reports First Quarter 2026 Results * Signed First Commercial Partners in Leading Concierge Practices ClearCardio™ and Atelier Health * Established Flagship Commercial Sites Across New York, Dallas, South Florida and Southern California * Strategic Collaboration with Mount Sinai to Accelerate Next-Generation AI-ECG Algorithms, Starting with Heart Attack Detection * Strengthened Balance Sheet with $11.5 Million Public Offering Including Full Exercise of Over-Allotment Option *

    Business Wire ·

  3. HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic

    HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic * Ambulatory patch device designed to aid in detecting ischemia and complex arrythmias * Targets a $2 billion market with established reimbursement; ischemia detection has potential to disrupt the patch market which is currently limited to atrial fibrillation detection HeartBeam, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=545331

    Business Wire ·

  4. HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

    HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice * Leading concierge practice Atelier Health, led by physicians affiliated with Cedars-Sinai, will now offer HeartBeam to its patients * Opens up flagship sites across New York, Dallas, South Florida and Southern California, supporting scalable expansion of HeartBeam technology in preventive cardiology * HeartBeam continues to execute on its go-to-market strategy in high-value, di

    Business Wire ·

  5. HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time

    HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time HeartBeam, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54525972&newsitemid=20260430142939&lan=en-US&anchor=HeartBeam%2C+Inc.&index=1&md5=30ea35114e526a0f6c4cfdb16d05b25b) (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, will hold a conference call on Wedne

    Business Wire ·

  6. HeartBeam Announces Closing of $10 Million Public Offering of Common Stock

    HeartBeam Announces Closing of $10 Million Public Offering of Common Stock Offering was led by HeartBeam’s first commercial customer, ClearCardio™ (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fclearcardio.com%2F&esheet=54516596&newsitemid=20260416675182&lan=en-US&anchor=ClearCardio%26%238482%3B&index=1&md5=e2899f0c6e7ba6eea5594f344ffe814c) , the Company's executive leadership, board members, and existing investors HeartBeam, Inc. (https://cts.businesswire.com/ct/CT?id=smar

    Business Wire ·

  7. HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock

    HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock Offering is being led by HeartBeam’s first commercial customer, ClearCardio™ (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fclearcardio.com%2F&esheet=54510442&newsitemid=20260414519110&lan=en-US&anchor=ClearCardio%26%238482%3B&index=1&md5=d1aadfbddd2db0010756eac8e884188d) , the Company's executive leadership, board members, and existing investors HeartBeam, Inc. (https://cts.businesswire.com/ct/CT?id

    Business Wire ·

  8. HeartBeam Announces Proposed Public Offering of Common Stock

    HeartBeam Announces Proposed Public Offering of Common Stock HeartBeam, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heartbeam.com%2F&esheet=54498595&newsitemid=20260413898771&lan=en-US&anchor=HeartBeam%2C+Inc.&index=1&md5=e80d664cfb28e1ad0eb34b884ff85118) (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that it is commencing an underwritten public offering of shares of its co

    Business Wire ·

  9. How Decentralized AI is Unlocking Value in Cardiac Diagnostics

    How Decentralized AI is Unlocking Value in Cardiac Diagnostics PR Newswire VANCOUVER,BC, March 27, 2026 ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER,BC, March 27, 2026 /PRNewswire/ -- USANewsGroup (https://usanewsgroup.com/2025/11/21/the-mri-grade-disruption-hiding-in-plain-sight-why-the-smart-money-is-watching-ventripoint) .com News Commentary – Heart disease is a quiet crisis that is draining healthcare resources worldwide, currently costing the European Union over €282 billion a

    PR Newswire ·

  10. HeartBeam Reports Fourth Quarter and Full Year 2025 Results

    HeartBeam Reports Fourth Quarter and Full Year 2025 Results * HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment * First Commercial Partner ClearCardio™ to Bring HeartBeam’s 3D ECG Technology to High-Growth Preventive Cardiology Market * First Patients Enrolled in Heart Attack Detection Pilot Study, A Key Step Toward Future FDA Indication Expansion * Completed the First Working Prototype of an Extended-We

    Business Wire ·